ATV/r 300mg+100mg tabs/PAC-30

Atazanavir 300mg+Ritonavir 100mg heat stable tablets in bottle packs of 30
Indicative Price : Upon Request
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Atazanavir 300mg +Ritonavir 100mg tablets, bottle pack of 30

Technical Specifications:
Each film coated tablet contains a fixed boosted protease inhibitor combination of Atazanavir 100mg + Ritonavir 100mg in a heat stable formulation.

Therapeutic class:
Protease Inhibitor (boosted)

Standard shelf life:
2 years (24 months)

Other available formulations:

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


WHO Essential Medicines Library

or your regional national guidelines

Management of HIV-1 infection of adults in combination with at least two other antiretroviral medicines. By mouth (oral), PO.

Do not store above 30ºC. Keep in original airtight container. Excursions permitted to 15-30ºC (59-86ºF). Protect from Moisture.
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack.
Tablets should be swallowed whole and not chewed, broken or crushed.
To be taken with food.
Warning: Formulation contains lactose

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines

List of USFDA approved and tentatively approved items

Important information regarding supply for this product

Please click on the link:
Related Products